Spasmodic Dysphonia

A severe hyperadductive voice disorder
A severe hyperadductive voice disorder.ppt

Spasmodic Dysphonia Evaluation and Management
Olvia Revelo, MSIV, Michael Underbrink, MD
dysphonia-slides.ppt

High Resolution MRI Microscopic Neuro-Imaging Studies and Voice Disorders
K. L. Watkin1, L. Ciobanu, S. London, P. Bajcsy
ModalVolumes/Watkin.ppt

Neurogenic Voice Disorders
Neurogenic Voice Disorders.ppt

Neurotoxin for the Treatment of Autonomic Disorders and Pain, Movement Disorders, and Spasticity
D.M. Simpson, MD; C.E. Argoff, MD; A. Blitzer, MD, DDS; etal
Neurotoxin for the Treatment of Autonomic Disorders.ppt

Voice and Voice Disorders
Voice and Voice Disorders.ppt

Psychosocial Aspects of Stuttering
Psychosocial Aspects of Stuttering.ppt

The Voice & Voice Disorders
Stephen Tasko
The Voice & Voice Disorders .ppt

Practice Guidelines in Dysarthria: Supplemented Speech
Elizabeth K. Hanson, M.S., CCC-SLP, Kathryn M. Yorkston, Ph.D., CCC-SLP, David R. Beukelman, Ph.D., CCC-SLP
Practice Guidelines in Dysarthria.ppt

Interferences with Ventilation Behavioral Objectives
Interferences with Ventilation Behavioral Objectives.ppt

Neuronal Function
Neuronal Function.ppt

Relaxation Techniques
Relaxation Techniques.ppt
33 free access articles

Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin.

Dejonckere PH, Neumann KJ, Moerman MB, Martens JP, Giordano A, Manfredi C.

Eur Arch Otorhinolaryngol. 2012 Apr;269(4):1195-203. Epub 2011 Dec 31.

Spasmodic dysphonia in Meige syndrome responding to clonazepam.

Hattori H, Yoshikawa F, Sato H, Fujimine T.

Intern Med. 2011;50(18):2061-2. Epub 2011 Sep 15. No abstract available.

Spasmodic dysphonia: a laryngeal control disorder specific to speech.

Ludlow CL.

J Neurosci. 2011 Jan 19;31(3):793-7. Review.

Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study.

Simonyan K, Ludlow CL.

Cereb Cortex. 2010 Nov;20(11):2749-59. Epub 2010 Mar 1.

Spasmodic dysphonia, perceptual and acoustic analysis: presenting new diagnostic tools.

Siemons-Lühring DI, Moerman M, Martens JP, Deuster D, Müller F, Dejonckere P.

Eur Arch Otorhinolaryngol. 2009 Dec;266(12):1915-22.

Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.

Upile T, Elmiyeh B, Jerjes W, Prasad V, Kafas P, Abiola J, Youl B, Epstein R, Hopper C, Sudhoff H, Rubin J.

Head Face Med. 2009 Oct 24;5:20.

Brainstem pathology in spasmodic dysphonia.

Simonyan K, Ludlow CL, Vortmeyer AO.

Laryngoscope. 2010 Jan;120(1):121-4.

Developing the communicative participation item bank: Rasch analysis results from a spasmodic dysphonia sample.

Baylor CR, Yorkston KM, Eadie TL, Miller RM, Amtmann D.

J Speech Lang Hear Res. 2009 Oct;52(5):1302-20. Epub 2009 Aug 28.

Differentiating between adductor and abductor spasmodic dysphonia using airflow interruption.

Hoffman MR, Jiang JJ, Rieves AL, McElveen KA, Ford CN.

Laryngoscope. 2009 Sep;119(9):1851-5.

Treatment for spasmodic dysphonia: limitations of current approaches.

Ludlow CL.

Curr Opin Otolaryngol Head Neck Surg. 2009 Jun;17(3):160-5. Review.

Research priorities in spasmodic dysphonia.

Ludlow CL, Adler CH, Berke GS, Bielamowicz SA, Blitzer A, Bressman SB, Hallett M, Jinnah HA, Juergens U, Martin SB, Perlmutter JS, Sapienza C, Singleton A, Tanner CM, Woodson GE.

Otolaryngol Head Neck Surg. 2008 Oct;139(4):495-505. Review.

Vocal aging and adductor spasmodic dysphonia: response to botulinum toxin injection.

Cannito MP, Kahane JC, Chorna L.

Clin Interv Aging. 2008;3(1):131-51. Review.

Focal white matter changes in spasmodic dysphonia: a combined diffusion tensor imaging and neuropathological study.

Simonyan K, Tovar-Moll F, Ostuni J, Hallett M, Kalasinsky VF, Lewin-Smith MR, Rushing EJ, Vortmeyer AO, Ludlow CL.

Brain. 2008 Feb;131(Pt 2):447-59. Epub 2007 Dec 14.

Psychiatric comorbidity in patients with spasmodic dysphonia: a controlled study.

Gündel H, Busch R, Ceballos-Baumann A, Seifert E.

J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1398-400. Epub 2007 Jul 5.

Adduction spasmodic dysphonia, vocal tremor and muscular tension dysphonia: is it possible to reach a differential diagnosis?

Imamura R, Tsuji DH.

Braz J Otorhinolaryngol. 2006 Jul-Aug;72(4):434. No abstract available.

Impact in vocal quality in partial myectomy and neurectomy endoscopic of thyroarytenoid muscle in patients with adductor spasmodic dysphonia.

Tsuji DH, Chrispim FS, Imamura R, Sennes LU, Hachiya A.

Braz J Otorhinolaryngol. 2006 Mar-Apr;72(2):261-6.

The psychosocial consequences of BOTOX injections for spasmodic dysphonia: a qualitative study of patients' experiences.

Baylor CR, Yorkston KM, Eadie TL, Maronian NC.

J Voice. 2007 Mar;21(2):231-47. Epub 2006 Mar 29.

Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.

Stong BC, DelGaudio JM, Hapner ER, Johns MM 3rd.

Arch Otolaryngol Head Neck Surg. 2005 Sep;131(9):793-5.

The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Baylor CR, Yorkston KM, Eadie TL.

J Commun Disord. 2005 Sep-Oct;38(5):395-419.

Postextubation laryngospasm in a patient with spasmodic dysphonia.

Capacchione JF, Bodily K, Hudson AJ.

Anesthesiology. 2005 Apr;102(4):859-60. No abstract available.

Chiropractic care for a patient with spasmodic dysphonia associated with cervical spine trauma.

Waddell RK.

J Chiropr Med. 2005 Winter;4(1):19-24.

Perceptual analyses of spasmodic dysphonia before and after treatment.

Cannito MP, Woodson GE, Murry T, Bender B.

Arch Otolaryngol Head Neck Surg. 2004 Dec;130(12):1393-9.

Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.

Rubin AD, Wodchis WP, Spak C, Kileny PR, Hogikyan ND.

Arch Otolaryngol Head Neck Surg. 2004 Apr;130(4):415-20.

Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia.

Benninger MS, Gardner G, Grywalski C.

Arch Otolaryngol Head Neck Surg. 2001 Sep;127(9):1083-5.

Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.

Mehta RP, Goldman SN, Orloff LA.

Arch Otolaryngol Head Neck Surg. 2001 Apr;127(4):393-9.

Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia.

Bhattacharyya N, Tarsy D.

Arch Otolaryngol Head Neck Surg. 2001 Apr;127(4):389-92.

[Use of botulinum toxin in the treatment of laryngeal dystonia (spasmodic dysphonia): preliminary study of twelve patients].

Teive HA, Scola RH, Werneck LC, Quadros Ad, Gasparetto EL, Sá DS, Brandi IV, Macedo Filho ED.

Arq Neuropsiquiatr. 2001 Mar;59(1):97-100. French.

Recurrent postoperative stridor requiring tracheostomy in a patient with spasmodic dysphonia.

Banoub M, Rao U, Motta P, Tetzlaff JE, Eliachar I, Blitzer A.

Anesthesiology. 2000 Mar;92(3):893-5. No abstract available.

Female predominance in spasmodic dysphonia.

Adler CH, Edwards BW, Bansberg SF.

J Neurol Neurosurg Psychiatry. 1997 Nov;63(5):688. No abstract available.

Spasmodic dysphonia and laryngeal botulinum toxin injection.

Smith ME.

West J Med. 1993 Jul;159(1):74. No abstract available.

The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.

Whurr R, Lorch M, Fontana H, Brookes G, Lees A, Marsden CD.

J Neurol Neurosurg Psychiatry. 1993 May;56(5):526-30.

Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.

Jankovic J, Schwartz K, Donovan DT.

J Neurol Neurosurg Psychiatry. 1990 Aug;53(8):633-9.

Clinical aspects of spasmodic dysphonia.

Aminoff MJ, Dedo HH, Izdebski K.

J Neurol Neurosurg Psychiatry. 1978 Apr;41(4):361-5.